跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
T-61
首页
药物
T-61
T-61
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
WDRPUH EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
EP 4047009 A3
申请人: ONCOTHERAPY SCIENCE INC
优先权: 2008
CN
EP
US
7 件公开
ANTI-CD22 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC CONSTRUCTS
EP 4188952 A4
申请人: NAT RES COUNCIL CANADA
优先权: 2020
CN
EP
US
WO
5 件公开
Cancer antigen peptide and the use thereof
US 7902143 B2
申请人: TORAY INDUSTRIES
优先权: 2004
CN
US
3 件公开
STAT3 EPITOPE PEPTIDES
US 2011052614 A1
申请人: ONCOTHERAPY SCIENCE INC
优先权: 2008
CN
US
2 件公开
MART-1(27-35) epitope-specific T cell receptor
US 12134637 B2
申请人: BGI SHENZHEN
优先权: 2018
CN
US
2 件公开
New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
CN 1552712 A
申请人: SERVIER LAB
优先权: 1999
CN
2 件公开
Isolation and identification of cross-reactive T cells
US 7972848 B2
申请人: OPEXA THERAPEUTICS INC
优先权: 2009
US
2 件公开
Peptides suitable for use in antigen specific immunosuppressive therapy
US 6881824 B1
申请人: AKZO NOBEL NV
优先权: 2000
US
Non symmetric 2-pyridinium diazo compounds with a cationic or non cationic linking group, compositions comprising them, a dying process and kit thereof
EP 1671951 A1
申请人: OREAL
优先权: 2004
EP
Dissymmetrical diazo dyes and their use in hair colouring compositions
EP 1671952 A1
申请人: OREAL
优先权: 2004
EP
第 1 / 3 页
上一页
下一页
药物
反馈